UPDATE : Thursday, December 12, 2019
상단여백
2 orphan drugs find manufacturers in Korea by Lee Hye-seon 2017-10-12 15:48
Roche Korea’s lung cancer drug increases cost-effectiveness by Marian Chu 2017-10-12 14:59
Rethink obesity, says Novo Nordisk Korea by Marian Chu 2017-10-12 11:20
AstraZeneca’s ovarian cancer drug more affordable by Marian Chu 2017-10-11 18:14
Boryung to sell antihypertensive drugs in SE Asia by Lee Hye-seon 2017-10-11 16:02
라인
Daewoong to sell Novartis’ osteoporosis drug by Marian Chu 2017-10-11 11:39
Green Cross units sign MOU with Sudan Central Lab by Lee Han-soo 2017-10-10 15:53
SK Chemicals ‘Skyzoster’ wins sales approval by Lee Han-soo 2017-10-10 12:16
Immunotherapy developers engage in fierce competition to expand indications by Marian Chu 2017-10-05 06:00
Dongkook Pharm, Madagascar government to develop natural medicines by Lee Han-soo 2017-09-29 17:39
라인
AbbVie’s hepatitis C treatment approved in Japan by Marian Chu 2017-09-29 12:03
Korea lags behind osteoporosis prevention and treatment by Marian Chu 2017-09-29 10:21
World’s best-selling drug Humira gains insurance coverage in Korea by Marian Chu 2017-09-28 19:02
Amgen Korea’s osteoporosis treatment gets insurance coverage by Marian Chu 2017-09-28 19:02
Korean drugmakers’ smart factories at ‘base level’ by Nam Doo-hyun 2017-09-28 16:00
라인
Drugmakers need to differentiate big data from ‘large data’ by Nam Doo-hyun 2017-09-27 17:44
Exelixis’ kidney cancer drug gains approval in Korea by Marian Chu 2017-09-27 17:44
Korean combos, incrementally modified drugs to get insurance benefits by Lee Hye-seon 2017-09-27 11:29
Ilyang presents leukemia treatment’s clinical results by Lee Han-soo 2017-09-26 17:31
Ministry changes dosage recommendation for Bayer’s blood-thinning drug by Marian Chu 2017-09-26 16:24
-이전81828384858687-
GC Labcell releases trial results of NK-cell combination treatmentGC Labcell releases trial results of NK-cell combination treatment
여백
Most viewed
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top